Filing Flows › Thermo Fisher Scientific (TMO) › Q2 2025
Thermo Fisher Scientific (TMO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 1, 2025
Thermo Fisher Scientific (TMO) reported revenue of $10.9B for the second quarter 2025 (Q2 2025), +3% from a year earlier and +5% from the quarter before. Operating margin was 16.9%, net earnings $1.6B (14.9% of revenue).
Thermo Fisher Scientific, Q2 2025: revenue $10.9B (+3% year over year), operating margin 16.9%, net earnings $1.6B, operating cash flow $1.4B. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.9B | +5% | +3% |
| Operating profit | $1.8B | +7% | +0.8% |
| Net earnings | $1.6B | +7% | +4% |
| Operating cash flow | $1.4B | +93% | -29% |
| Free cash flow | $1.1B | +206% | -33% |
What changed
Revenue was $10.9B in Q2 2025, up 3% year over year and up 5% from the previous quarter. Laboratory Products and Biopharma Services was the largest line at 55% of revenue. Laboratory Products and Biopharma Services added $0.23B year over year (up 4%), 75% of the total change. Analytical Instruments declined 3%.
Operating profit was $1.8B, a 16.9% margin (down 0.4 points year over year). Of the extra revenue versus a year earlier, 4% reached operating profit, below the 17% margin then. Total costs grew 3% against revenue growth of 3%. Net earnings were $1.6B, up 4% year over year. The effective tax rate was 5.4%.
Operating cash flow was $1.4B (down 29% year over year), 86% of net earnings. Non-cash charges added back $0.69B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $1.0B. Capital expenditures of $0.29B left free cash flow of $1.1B.
Questions
What was Thermo Fisher Scientific's revenue in the second quarter 2025?
Thermo Fisher Scientific (TMO) reported revenue of $10.9B for the second quarter 2025 (Q2 2025), +3% from a year earlier and +5% from the quarter before.
Was Thermo Fisher Scientific profitable in the second quarter 2025?
Operating profit was $1.8B (16.9% of revenue) and net earnings $1.6B.